Bio Investor, Entrepreneur, Philanthropy, Dad. Insta: Sheffbiotech. Get it Done! Not InvestAdvice! @VIPSheffTrades-https://nitter.gq/t.co/jw2hZa7L7S
US
Joined July 2010
- Tweets28.7K
- Following115
- Followers92.5K
- Likes3.2K
Sheff retweeted
Did you know?
Vance Sheffield has three game-winning goals this season, which leads the @HorizonLeague and is tied for fourth-best in the nation.
Sheff retweeted
Rein presenting late-breaking poster at #ERS2026 in Barcelona highlighting data from our randomized dose-escalation study of inhaled LTI-03 in idiopathic pulmonary fibrosis.
📅 Sept. 8 | 12:30–2:00 p.m. CEST
📍 Poster PA6217
🎤 Philip Molyneaux, MD
Data published in Nature Communications.
$RNTX #IPF #PulmonaryFibrosis
Sheff retweeted
CEO Brian Windsor will present at two investor conferences in NYC this September:
📍 Cantor Global Healthcare Conference
Sept. 11 | 8:00 a.m. ET
📍 H.C. Wainwright Global Investment Conference
Sept. 14 | 11:00 a.m. ET
Watch the presentations live through the Events & Presentations section of our website, with replays available afterward.
$RNTX
Sheff retweeted
🟢 INSIDER BUY — $PTIX
Armen Garo H buys $13K
• 20,000 shares @ $0.65
• Position +37%
• Stock −87% from 52W high
• Trade: Aug 21, 2026 | Filed: Aug 24, 2026
💡 Moderate Signal
#InsiderTrading #PTIX
Sheff retweeted
Ryan Swan Receives Contract Extension niuhuskies.com/news/2026/8/1…
Sheff retweeted
🚨🚨🚨BREAKING CANCER NEWS! 🚨🚨🚨
Merck $MRK and Moderna $MRNA personalized mRNA cancer vaccine slowed the return of melanoma and its spread to other parts of the body in a Ph3 clinical trial.
No data disclosed yet, but the study was stopped for positive results at the first interim analysis.
Magnitude of benefit TBD, but this is a potentially huge breakthrough for cancer patients and the use of mRNA to treat cancer.
Read STAT's story from @matthewherper and @angRchen
statnews.com/2026/08/19/mrna…
Sheff retweeted
How does a small biotech firm turn years of regulatory setbacks into a pivotal FDA appeal victory?
John Gagliano and @SheffStation sit down to analyze $OTLK 's upcoming June resubmission and the massive valuation potential behind it.
We dive deep into:
1️⃣ The strategic impact of the “One Pivotal Study” rule. 2️⃣ How this victory creates a roadmap for other firms. 3️⃣ The explosive growth of FDA de novo approvals for AI medical devices.
Get the full breakdown on navigating the high-stakes world of biotech:
youtu.be/U9BT2QHjwBQ?si=ueOZ…
#Biotechtrading #FDA #HealthTech #Investing #biotech #biotechstocks #stocks #trading
Sheff retweeted
🟢 DIRECTOR BUY — $OTLK
Sukhtian Faisal Ghiath buys $50K
• 122,174 shares @ $0.41
• New/major position
• Stock −88% from 52W high
• Trade: May 27, 2026 | Filed: May 27, 2026
💡 Moderate Signal
#InsiderTrading #OTLK
Sheff retweeted
$OTLK announced the FDA granted its Formal Dispute Resolution appeal, concluding that substantial evidence of effectiveness supports ONS-5010/LYTENAVA for neovascular AMD, clearing the path for a June 2026 BLA resubmission with a potential 60-day Class 1 review timeline and positioning LYTENAVA as the first FDA-approved ophthalmic bevacizumab formulation if approved.
$OTLK $LLY $SNGX $PHGE $DYN $MDAI $ARTL $QNTM $ADTX $AKTX
See More Pre-market Movers
biopharmcatalyst.com/news/20…
Sheff retweeted
🚨 Weekly Watchlist: Phase 3 Readouts are coming before 2Q ends.
$ADCT, $PTN, and $DFTX are all approaching clinical data. 📈🧬
🔹 $ADCT: LOTUS-5 data
🔹 $PTN: ED Synergistic data
🔹 $DFTX: MDD Phase 3 data
Watch now: youtube.com/shorts/GWl7EgyYl… 📺
Weekly Watchlist:
biopharmcatalyst.com/news/20…
Track the countdown at BioPharmCatalyst.com 📈
#Biotech #Stocks #Trading #ADCT #PTN #DFTX #BioPharmCatalyst
Sheff retweeted
.@rdswan10 presenting the guys with their 💍 to commemorate the accomplishments of the 2025 season.
Sheff retweeted
Biotech is showing its resilience! 🧬📷 In our latest episode, John Gagliano and Sheff Sheffield dive deep into the mid-2026 outlook. From the White House’s new stance on psychedelics to the regulatory hurdles facing $OTLK, we’re breaking down what you need to know.
Highlights:
🍄 The WH Medical Executive Order on Psychedelics
⚖️ $OTLK’s FDR meeting with the FDA
📈 Sheff’s high-conviction Watchlist for 2026
Catch the full breakdown of #AACR26 & #ASCO26 impacts here:
youtube.com/watch?v=tSk02XN5…
#Biotech #StockMarket #FDA #Psychedelics #Investing $IBB
the full breakdown of AACR & ASCO impacts here: N5zgo #biotechstocks #stocks #biotechtrading #biotech #StockMarket #psychedelics #Investing $IBB $XBI
Sheff retweeted
Congratulations to Huskie Newcomer of the Year winners, Emilie Sorensen of @GoHuskiesWBB and Vance Sheffield of @NIUMSoccer
🤖 Made with AI
Sheff retweeted
Congratulations Vance!
Congratulations to Huskie Newcomer of the Year winners, Emilie Sorensen of @GoHuskiesWBB and Vance Sheffield of @NIUMSoccer
Sheff retweeted
YES, YES, YES, SHEFFIELD!!!!
So awesome & CONGRATULATIONS!💪🏻
@SheffStation @rdswan10
Sheff retweeted
The "two-trial dogma" is over. 🧬
The FDA's new one-pivotal-trial shift is the new default for 2026, and it’s rewriting trial timelines and cash runways. In biotech, this isn't just a rule change—it's a survival metric.
Full breakdown with John & @SheffStation :
🎧listen here: youtube.com/watch?v=0EGusAkr…
#biotech #FDA #stocks #investing
Sheff retweeted
$AARD voluntarily paused its Phase 3 HERO trial of ARD-101 in Prader-Willi Syndrome after reversible cardiac findings at supratherapeutic doses in a healthy volunteer study, delaying planned 3Q26 topline data and introducing regulatory and timing uncertainty as the company reassesses dosing and safety in collaboration with the FDA.
$AARD $QURE $CGEN $NTLA $TCRT $BCAB $XERS $MYGN $CDIO $ENSC
See More Pre-market Movers
biopharmcatalyst.com/news/20…
